Stay updated on Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial

Sign up to get notified when there's something new on the Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T06:23:39.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about the study, including the EudraCT number and collaborators, while significant details about the study's design, participant criteria, and locations have been removed.
    Difference
    11%
    Check dated 2025-04-16T20:40:04.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T15:00:41.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-02T00:20:24.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The webpage has removed important information regarding the performance and availability of NLM-NCBI services, as well as contact information for BioNTech SE study centers.
    Difference
    0.5%
    Check dated 2025-02-24T23:09:22.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.3%
    Check dated 2025-02-10T16:41:12.000Z thumbnail image

Stay in the know with updates to Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial page.